MedPath

Validation Study of Sleep Tracking Devices

Completed
Conditions
Sleep Disorder
Sleep
Interventions
Device: Sleep tracking device
Registration Number
NCT06357039
Lead Sponsor
PNAPS Health Informatics and Space Technologies Inc.
Brief Summary

In this study, a two-part recursive convolutional neural networks model was developed, extracting features for each epoch window independently from before and after sleep onset (epoch encoder), and then trained in the context of long-term relationships in the sleep process (sequence encoder), using an approach similar to human expert classification based on information from single-channel forehead EEG and PPG (IR, Green, Red). The classification is based on guidelines from the American Academy of Sleep Medicine and calculated six parameters: total sleep duration (TST), wake (W), N1, N2, N3, and REM.

The validation study of the developed model and the device was conducted at the Sleep Disorders Centre of the Istanbul Medical Faculty using concurrent polysomnographic data from 305 male and female patients aged 18 to 65 years.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
305
Inclusion Criteria
  • Participants suffering from sleep disorders
  • Participants sent to PSG test by neurologists, pulmonologists, psychiatrists, and otolaryngologists
Exclusion Criteria
  • Anyone who has been diagnosed as having a contagious skin disease
  • Participants who do not have consent to have an additional device in their forehead area
  • Incomplete of sleep measurement

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
FemaleSleep tracking deviceParticipants aged 18-65 who identify as female for biological
MaleSleep tracking deviceParticipants aged 18-65 who identify as male for biological
Primary Outcome Measures
NameTimeMethod
Sleep Stages Classification Accuracy4-5 months

The collected EEG data were classified according to Cohen's kappa (\>85), which is considered successful in the literature. Initially the open source codes YASA, tinysleepnet and attentionsleep have been implemented. These codes yielded kappa 0.64, accuracy 0.80, kappa 0.69, accuracy 0.79 and kappa 0.65, accuracy 0.78 respectively. The values obtained do not correspond to those reported in the classification articles. Subsequently, 29 participants from our own dataset were tested in these classifications as a preliminary test, with poor results. On an individual basis, the highest cappa score was 0.51. Development of our own classification system is in progress.

Interoception analysis from PPG data collected from facial skin4-5 months

According to our preliminary analyses, we found that the intermediary rhythm (0.12-0.18 Hz) associated with interoception is also present in sleep patients. In one participant, for example, a value of 0.19 was obtained as a ratio of total sleep time. In addition, an intermediary rhythm is observed in all stages of sleep, including wakefulness, light sleep, deep sleep and REM.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pnaps Health Informatics and Space Technologies Inc

🇹🇷

Istanbul, Başıbüyük, Maltepe, Turkey

Pnaps Health Informatics and Space Technologies Inc
🇹🇷Istanbul, Başıbüyük, Maltepe, Turkey
© Copyright 2025. All Rights Reserved by MedPath